Healthcare Industry - Medical - Pharmaceutical - Biotech in Amsterdam, Netherlands

We are thrilled to extend a warm welcome to the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), scheduled to take place from 19-22 March, 2025, in Amsterdam, The Netherlands. We invite you to join us at ATTD, the pre ..

Compared to five years ago, biopharma lab operations have undergone a transformation driven by tighter budgets, technological advancements, and the need for greater efficiency. Organisations today are focused on digitisation, automation, and sustainability while opti ..

Fortunately, new developments occur rapidly in all involved disciplines. New Gastroenterology techniques lead to earlier detection and better endoscopic treatment. New Radiology features lead to better staging, whereas new Surgical techniques, like sentinel node, lap ..

The "10th International Conference on Future Pharma and Innovations," scheduled for September 23-24, 2025, in Amsterdam, Netherlands, and largely focused on the theme "Innovations in Pharma: Pioneering the Future of Healthcare" is cordially invited to participants fr ..

This year has been the year for radiopharmaceuticals, with market projections estimating to grow to $39 billion by 2032. More patients are being treated by Pluvicto and Lutathera than ever before, companies advancing their pipelines across a range of targeting moieti ..

Brought to you by HMP Global and GTGL Global Events Ltd, AMP Europe is an expansion of the Amputation Prevention Symposium (AMP), the flagship meeting taking place annually in August in Chicago and now in its 14th year. AMP is an unrivaled CME meeting focused on the ..

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and c ..

With the EMA's guidance on the use of real world evidence in its regulatory decision-making, and federated learning networks that continue to support pharma, the integration of real world evidence into clinical research is transforming drug development. Following ..